Roth MKM raised the firm’s price target on Imax (IMAX) to $30 from $28 and keeps a Buy rating on the shares. The start of a strong 2-or-more-year content cycle is at hand, and the firm expects IMAX to further benefit from an expanding global footprint and a larger market share, the analyst tells investors in a research note. Roth adds that a greater operational scale should also help drive EBITDA margin expansion for IMAX.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX:
- Now Streaming: Imax to debut Netflix ‘Narnia’ film across its network in 2026
- IMAX Partners with Netflix for Exclusive Film Release
- Roth calls ‘Narnia’ deal with Netflix ‘significant’ for Imax
- Imax in pact with Netflix for ‘Narnia’ film release
- Imax sees much improved China market in 2025, says Roth MKM